[RDHL] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[RDHL] RedHill Biopharma Ltd.
Announcement Date
23-Feb-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -2.96%
YoY- -55.61%
Quarter Report
RDHL's Result
RDHL's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 1,056 1,737 2,445 0 0 1 7,005 -27.02%
PBT -17,157 -9,870 -9,935 -8,596 -5,524 -4,642 3,377 -
Tax 214 374 134 5 380 286 104 12.76%
NP -17,157 -9,870 -9,935 -8,596 -5,524 -4,642 3,377 -
Tax Rate - - - - - - -3.08% -
Total Cost 18,213 11,607 12,380 8,596 5,524 4,643 3,628 30.82%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -1,624.72 -568.22 -406.34 0.00 0.00 -464,200.00 48.21 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -19.46 -13.92 -18.64 -20.22 -17.38 -19.82 16.00 -
EPS Diluted -19.46 -13.92 -18.64 -20.22 -17.38 -19.82 16.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.